CHA2DS2-VASc or a non-sex score (CHA2DS2-VA) for stroke risk prediction in atrial fibrillation: contemporary insights and clinical implications
Gregory Y.H. Lip, Konsta Teppo, Peter Brønnum Nielsen
Abstract
CHA2DS2-VASc [congestive heart failure, hypertension, age ≥75 years (doubled), diabetes, stroke/transient ischaemic attack/thromboembolism (doubled), vascular disease, age 65–74 years, sex category (female)]; CHA2DS2-VA [congestive heart failure, hypertension, age ≥75 years (doubled), diabetes, stroke/transient ischaemic attack/thromboembolism (doubled), vascular disease, age 65–74 years]; CHD-VASc [congestive heart failure, hypertension, diabetes, stroke/transient ischaemic attack/thromboembolism (doubled), vascular disease, age 65–74 years, sex category (female)]; CHD-VA [congestive heart failure, hypertension, diabetes, stroke/transient ischaemic attack/thromboembolism (doubled), vascular disease, age 65–74 years].